Amphenol (APH)


April 26, 2023

APH: First Look at Q1 Results and Outlook

By Steven Fox

Amphenol (APH; $74.87; E/W) reported Q1 non-GAAP EPS of $0.69, which was ahead of our $0.66 and the Street’s $0.67 led by some sales upside ($2,974mm vs. our $2,888mm and the Street’s $2,901mm). As per…

Read More >>

April 18, 2023

APH: Incremental Challenges to Consider into Q1 Print

By Steven Fox

We assume Amphenol (APH; $78.25; E/W) posts a third consecutive “beat and lower” quarter when it releases Q1 results and outlook next Wednesday (4/26 before market) led by our concerns, albeit within a mix bag…

Read More >>

January 26, 2023

APH: Another Beat and Lower

By Steven Fox

We reduce 2023E EPS for Amphenol (APH; $78.41; E/W) from $3.05 to $2.92 (-3% YoY) after the company produced a second consecutive “beat and lower” quarter, including a just completed acquisition now in our model…

Read More >>

January 25, 2023

APH: First Look at Q4 Results and Outlook

By Steven Fox

Amphenol (APH; $79.44; E/W) reported Q4 non-GAAP EPS of $0.78, which was ahead of our consensus matching $0.75 led by some sales upside ($3,239mm vs. our $3,154mm and the Street’s $3,151mm). As per the table…

Read More >>

October 27, 2022

APH: A Little More Right Now, A Little Less Next Time

By Steven Fox

We make some relatively small adjustments to our 2022/2023E EPS for Amphenol (APH; $73.19; E/W), from $2.93/$3.07 to $2.98/$3.05, after the company produced one of its typically healthy types of EPS beats in Q3, albeit…

Read More >>

October 26, 2022

First Look at Q3 Results and Outlook

By Steven Fox

Amphenol (APH; $73.01; E/W) reported Q3 non-GAAP EPS of $0.80, which beat our $0.74 and the Street’s $0.75 on better than expected sales ($3,295mm vs. our $3,100mm and the Street’s $3,113mm). As per the variance…

Read More >>

October 19, 2022

Expect Q3 Results and Outlook to Hold Up

By Steven Fox

We expect our 2022/2023E EPS for Amphenol (APH; $70.07; E/W) to generally “hold up” after it reports Q3 results and outlook next Wednesday (10/26 before market) given the healthy current state of backlogs. We assume…

Read More >>

July 28, 2022

Seeing Limited Macro Concerns

By Steven Fox

Read More >>

July 7, 2022

Reducing Estimates

By Steven Fox

Read More >>

April 27, 2022

First Look at Q1 Results and Outlook

By Steven Fox

Read More >>